Full name
"SWISS-LAB" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.46.Z - Wholesale of pharmaceutical goods
47.91.Z - Retail sale via mail order houses or via Internet
63.12.Z - Web portals
86.90.E - Other human health activities notelsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,4 | 0,4 | 3,1 | |
Gross profit (loss) | 0 | 0,3 | 0,4 | 7,5 |
EBITDA | 0,5 | 17,9 | ||
Short time liabilities | 0,1 | 0,1 | 0,1 | -4,5 |
Other operating costs | 0 | 0 | -100 | |
Equity capital | 1,1 | 1,4 | 1,7 | 24,1 |
Operating profit (EBIT) | 0,5 | 0,3 | 0,4 | 7,8 |
Assets | 1,2 | 1,5 | 1,9 | 23,7 |
Net profit (loss) | 0,4 | 0,3 | 0,3 | 8,8 |
Cash | 0 | 0,5 | 0,8 | 70,3 |
Liabilities and provisions for liabilities | 0,1 | 0,1 | 0,2 | 20 |
Net income from sale | 1,9 | 1,6 | 1,6 | 3,4 |
Working assets | 1,2 | 1,5 | 0,8 | -45,1 |
Other income costs | 0 | 0 | 46 670,7 | |
Depreciation | 0 | -∞ | ||
% | % | % | p.p. | |
Profitability of capital | 39 | 22,1 | 19,4 | -2,7 |
Equity capital to total assets | 89,3 | 91,7 | 92 | 0,3 |
Gross profit margin | 0 | 21,8 | 22,7 | 0,9 |
EBITDA Margin | 26,1 | -7,2 | ||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 25 | 24 | 23 | -1 |
Current financial liquidity indicator | 14.483760833740234 | 8.320578575134277 | -6,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane